This study evaluates a new aqueous nasal formulation of ipratropium bromide (Atrovent Nasal Spray 0.03%) in subjects with perennial non-allergic rhinitis in a double-blind, placebo-controlled trial.
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. Epistaxis, pharyngitis, nasal dryness ...
Ipratropium bromide 0.06% (42mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. <5yrs: not recommended.
Medically reviewed by Corinne Savides Happel, MDIf your nose sometimes runs when you eat, you could have gustatory rhinitis.
Trump’s Truth Social reaction ran on with the next statement that hit right on the nose (and eyes): “She ... such as Allegra (fexofenadine), Atrovent (ipratropium bromide) nasal spray and ...
Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...
including fexofenadine (Allegra), ipratropium bromide (Atrovent) nasal spray, and olopatadine (Pataday) eye drops. Harris has also been receiving allergen immunotherapy for the past 3 years ...
In this instance, antihistamine pills may again be of value, along with the nasal spray Atrovent, which blocks the action of the neurotransmitter released by the parasympathetic nerves.
A nasal spray to help obese people lose weight has been developed by scientists. The spray contains a hormone which makes people feel full after they have eaten. In tests, it reduced the amount ...
Vexed by taunts about his own medical situation, former President Donald Trump warned Tuesday that Vice President Kamala Harris’ allergies could prevent her from serving effectively. “I have ...
In April, she’d begun to use a topical nasal-spray decongestant. The over-the-counter (OTC) drug worked like a charm. By summer, she was still using the spray daily. Yet it was helping for ...
FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...